Furthermore, a study demonstrated that miR-22 is downregulated in MCF-7 and MDA-MB-231 breast cancer cells, and the overexpression of miR-22 or SIRT1 knockdown induces apoptosis and decreases the survival of breast cancer cells [209]. This evidence concerns the gene SIRT1 and breast carcinoma.